Yahoo Finance • 6 days ago
Carlsbad, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced a series of key leadership and governance changes aimed at strengthening its executive team, enhancing financial t... Full story
Yahoo Finance • 7 days ago
FF has finalized the U.S. production assembly plan for FX Super One. The Company’s bridge partners and supply chain collaborators will now commence component supply for the production assembly phase. This week, FF successfully closed a str... Full story
Yahoo Finance • 12 days ago
New York, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of $41 mill... Full story
Yahoo Finance • 13 days ago
Carlsbad, CA, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or “the Company”) today announced the successful closing of a $41 million private investment in public equity (PIPE) financing led by... Full story
Yahoo Finance • 13 days ago
QLGN is expected to rebrand as CXC10 soon, reflecting its new strategic direction around crypto and web3 business. LOS ANGELES, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”... Full story
Yahoo Finance • 20 days ago
Qualigen Therapeutics (QLGN) [https://www.barchart.com/quotes/QLGN] shares soared about 200% on Monday at the peak after the biotech company secured a $41 million investment from Faraday Future (FFAI) [https://www.barchart.com/quotes/FFAI]... Full story
Yahoo Finance • 21 days ago
(RTTNews) - Shares of Qualigen Therapeutics Inc. (QLGN) are up over 200% in premarket trading on Monday, following a $41 million strategic investment by Faraday Future Intelligent Electric Inc. (FFAI), a California-based global shared inte... Full story
Yahoo Finance • 21 days ago
* Faraday Future (NASDAQ:FFAI [https://seekingalpha.com/symbol/FFAI]) said on Sunday that it is strategically investing [https://seekingalpha.com/pr/20239048-faraday-future-announced-a-total-strategic-investment-of-41-million-in-qualigen... Full story
Yahoo Finance • 21 days ago
Faraday Future is making an investment of approximately $30 million in Qualigen Therapeutics (“QLGN”); FF Founder and Co-CEO YT Jia will invest approximately $4 million (via an FFGP loan) in QLGN with a two-year lockup.The strategic invest... Full story
Yahoo Finance • 23 days ago
LOS ANGELES and CARLSBAD, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem... Full story
Yahoo Finance • 23 days ago
LOS ANGELES and CARLSBAD, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company,... Full story
Yahoo Finance • 3 months ago
CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualifications office of the Nasdaq Stock Market, L... Full story
Yahoo Finance • 3 months ago
Carlsbad, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company focused on developing platform treatments for adult and pediatric cancers with the potential... Full story
Yahoo Finance • 3 months ago
CARLSBAD, Calif. - Qualigen Therapeutics, Inc. (NASDAQ:QLGN), a small-cap biotech with a market capitalization of $5.77 million, announced Wednesday that it has secured multiple patents for its cancer drug QN-302 across Europe, India, Chin... Full story
Yahoo Finance • 3 months ago
Qualigen Therapeutics, Inc. CARLSBAD, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company” or “Qualigen”) is announcing an update on patents granted in the first six months of 2025. The paten... Full story
Yahoo Finance • 5 months ago
CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq... Full story
Yahoo Finance • 2 years ago
Initiated dosing of three patients in first cohort of Phase 1 clinical trial of QN-302 for treatment of advanced or metastatic solid tumorsPhase 1a patient recruitment ongoing; company anticipates sharing update on safety and preliminary e... Full story
Yahoo Finance • 2 years ago
CARLSBAD, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designa... Full story
Yahoo Finance • 2 years ago
Poster Includes Preclinical Data on Pan-RAS Compounds Demonstrating Inhibition in Breast Cancer Models CARLSBAD, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company... Full story
Yahoo Finance • 2 years ago
Two posters include data on potential clinical biomarkers and transcriptomic data associated with QN-302’s mechanism of action CARLSBAD, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-s... Full story